Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of organ transplants
3.2.1.2 Promising pipeline for different indications
3.2.1.3 Advancements in drug delivery systems
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects associated with sirolimus
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Organ transplant rejection
5.3 Lymphangioleiomyomatosis (LAM)
5.4 Sirolimus coated balloons and catheter devices
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Injection
6.3 Tablets
Chapter 7 Market Estimates and Forecast, By Dosage, 2021– 2032 ($ Mn)
7.1 Key trends
7.2 0.5mg
7.3 1mg
7.4 2mg
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Accord Healthcare Limited
10.2 Apotex Inc.
10.3 Amneal Pharmaceuticals, Inc.
10.4 Actiza Pharmaceutical Private Limited
10.5 Biocon Limited
10.6 Concept Medical
10.7 Concord Biotech
10.8 Dr. Reddy's Laboratories Ltd.
10.9 Intas Pharmaceuticals Ltd.
10.10 Livzon Pharmaceuticals Group Inc.
10.11 Pfizer Inc.
10.12 Tiefenbacher API + Ingredients GmbH & Co. KG
10.13 Torrent Pharmaceuticals Ltd.
10.14 Zydus Group
